“The clinical and real-world data at ASRS reinforce the improvement in outcomes brought by Vabysmo in two leading causes of vision loss, particularly new analyses suggesting that Vabysmo is ...

In this video, Barbara Blodi, MD, discusses early data on neuroprotective agents for the treatment of geographic atrophy.In a phase 1b study presented during a dry AMD symposium at the ASRS ...